37 insiders have filed at SHC since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.
| name | role | reported stake | % of company | buys (3y) | sells (3y) |
|---|---|---|---|---|---|
| Warburg Pincus & Co. | Director | 19.10M | 6.642% | 12 sells $2.63B | |
| Warburg Pincus Xi-C, Llc | Director | 19.10M | 6.642% | 7 sells $1.47B | |
| Warburg Pincus Llc | Director | 19.10M | 6.642% | 7 sells $1.47B | |
| Warburg Pincus (bermuda) Private Equity Gp Ltd. | Director | 19.10M | 6.642% | 7 sells $1.47B | |
| Warburg Pincus Partners Gp Llc | Director | 19.10M | 6.642% | 7 sells $1.47B | |
| Warburg Pincus Partners II (cayman), L.P. | Director | 19.10M | 6.642% | 7 sells $1.47B | |
| Warburg Pincus (cayman) Xi, L.P. | Director | 19.10M | 6.642% | 7 sells $1.47B | |
| Warburg Pincus Private Equity Xi-C, L.P. | Director | 19.10M | 6.642% | 7 sells $1.47B | |
| Wp Global Llc | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Bull Holdco L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Warburg Pincus Partners II, L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Warburg Pincus Private Equity Xi, L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Wp Xi Partners, L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Warburg Pincus Private Equity Xi-B, L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Warburg Pincus Xi Partners, L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Bull Co-Invest L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Warburg Pincus Xi, L.P. | Director | 19.10M | 6.642% | 5 sells $1.15B | |
| Gtcr Partners Xi/A&c Lp | Director | 12.74M | 4.428% | 6 sells $875.8M | |
| Gtcr Fund Xi/C Lp | Director | 12.74M | 4.428% | 6 sells $875.8M | |
| Gtcr Fund Xi/A Lp | Director | 12.74M | 4.428% | 6 sells $875.8M | |
| Gtcr Co-Invest Xi Lp | Director | 12.74M | 4.428% | 6 sells $875.8M | |
| Gtcr Investment Xi Llc | Director | 12.74M | 4.428% | 6 sells $875.8M | |
| Petras Michael B. JR. | Chairman & CEO | 6.03M | 2.098% | 4 sells $26.7M | |
| Rutz Michael P | President Of Sterigenics | 930.8k | 0.324% | 2 sells $3.3M | |
| Dimitrief Alexander | SVP, General Counsel And Sec. | 646.8k | 0.225% | ||
| Lyons Jonathan M. | SR. Vice President, CFO | 412.2k | 0.143% | ||
| Klee Ann R. | Director | 126.0k | 0.044% | 1 sells $82k | |
| Petrella Vincent K | Director | 80.8k | 0.028% | ||
| Neary James | Director | 80.8k | 0.028% | ||
| Mihas Constantine S | Director | 80.8k | 0.028% | ||
| Cunningham Sean Laurence | Director | 80.8k | 0.028% | ||
| Chen Ruoxi | Director | 80.8k | 0.028% | ||
| Wheadon David E. | Director | 74.9k | 0.026% | ||
| Donnini David | Director | 61.6k | 0.021% | ||
| Knauss Robert Brown | Director | 54.9k | 0.019% | ||
| Flynn Karen | Director | 39.2k | 0.014% | ||
| Simon, Christopher | Director | 19.1k | <0.01% |
Full register at boothcheck.com/insiders/SHC. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.